Published in J Nucl Med on March 01, 1993
EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging (2005) 3.61
Validation of pixel-wise parametric mapping of myocardial blood flow with ¹³NH₃ PET in patients with hypertrophic cardiomyopathy. Eur J Nucl Med Mol Imaging (2015) 1.41
Relationship Between Quantitative Adverse Plaque Features From Coronary Computed Tomography Angiography and Downstream Impaired Myocardial Flow Reserve by 13N-Ammonia Positron Emission Tomography: A Pilot Study. Circ Cardiovasc Imaging (2015) 1.41
Dynamic single photon emission computed tomography--basic principles and cardiac applications. Phys Med Biol (2010) 1.24
Acceleration of the direct reconstruction of linear parametric images using nested algorithms. Phys Med Biol (2010) 0.92
Quantitative cardiac positron emission tomography: the time is coming! Scientifica (Cairo) (2012) 0.82
Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM). Eur J Nucl Med Mol Imaging (2016) 0.78
Positron emission tomography in paediatric cardiology. Arch Dis Child (1998) 0.76
Is the Patlak graphical analysis method applicable to measurement of myocardial blood flow with nitrogen-13-ammonia? J Nucl Med (1993) 0.75
Coronary vasomotor function assessed by positron emission tomography. Eur J Nucl Med Mol Imaging (2009) 0.75
Absolute quantitation of myocardial blood flow: the technical and clinical prospects for single-photon emission computed tomography. J Nucl Cardiol (1997) 0.75
Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol (1979) 5.83
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13
Positron emission tomography study of human brain functional development. Ann Neurol (1987) 4.89
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.85
A tabulated summary of the FDG PET literature. J Nucl Med (2001) 4.37
Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA (1995) 4.02
Ketone-body utilization by adult and suckling rat brain in vivo. Biochem J (1971) 3.32
Performance evaluation of microPET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging. J Nucl Med (1999) 3.31
A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci U S A (2000) 3.28
The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci (1998) 3.24
Quantitation in positron emission computed tomography: 1. Effect of object size. J Comput Assist Tomogr (1979) 3.18
The major facilitator superfamily. J Mol Microbiol Biotechnol (1999) 3.17
Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol (1980) 3.12
Human pharmacokinetic and dosimetry studies of [(18)F]FHBG: a reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression. J Nucl Med (2001) 3.03
The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr (1994) 2.88
Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci U S A (1999) 2.71
Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study. J Neurosurg (1997) 2.68
Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry (2001) 2.67
Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry (1989) 2.67
A simple method for the determination of oestrogen receptor concentrations in breast tumours and other tissues. Clin Chim Acta (1975) 2.64
Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. J Nucl Med (1996) 2.60
Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J Nucl Med (1998) 2.58
Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology (1997) 2.39
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology (2009) 2.37
Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. Circulation (1996) 2.31
Oestrogen receptors and breast cancer: current status. Br J Surg (1980) 2.31
Estrogen secretion by the rat ovary in vivo during the estrous cycle and pregnancy. Endocrinology (1969) 2.25
Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther (1999) 2.21
Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann Neurol (1990) 2.12
A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med (2000) 2.10
Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG. J Nucl Med (2001) 2.04
Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn (1987) 2.03
Imaging transgene expression with radionuclide imaging technologies. Neoplasia (2000) 2.03
Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry (1987) 1.98
Significance of aromatase activity in human breast cancer. Cancer Res (1982) 1.97
Application of annihilation coincidence detection to transaxial reconstruction tomography. J Nucl Med (1975) 1.97
Noninvasive methods for quantitating blood time-activity curves from mouse PET images obtained with fluorine-18-fluorodeoxyglucose. J Nucl Med (1998) 1.97
Positron emission tomography: human brain function and biochemistry. Science (1985) 1.92
A positron-emission transaxial tomograph for nuclear imaging (PETT). Radiology (1975) 1.87
Noninvasive quantitative imaging of protein-protein interactions in living subjects. Proc Natl Acad Sci U S A (2002) 1.85
The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer. Clin Nephrol (2002) 1.85
Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med (1990) 1.85
Reproducibility of measurements of oestrogen-receptor concentration in breast cancer. Br J Cancer (1977) 1.85
Noninvasive quantification of the cerebral metabolic rate for glucose using positron emission tomography, 18F-fluoro-2-deoxyglucose, the Patlak method, and an image-derived input function. J Cereb Blood Flow Metab (1998) 1.84
Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. J Nucl Med (1992) 1.83
Maturational changes in cerebral function in infants determined by 18FDG positron emission tomography. Science (1986) 1.81
Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation (1993) 1.81
Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation (1999) 1.80
8-[18F]Fluoropenciclovir: an improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET. J Nucl Med (2001) 1.80
Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3. Ann Neurol (1980) 1.78
13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation (1989) 1.77
Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Ann Neurol (1982) 1.77
Metabolic mapping of the brain's response to visual stimulation: studies in humans. Science (1981) 1.75
Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. J Neurosci (2001) 1.73
Comparative localization of epileptic foci in partial epilepsy by PCT and EEG. Ann Neurol (1982) 1.73
Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. J Am Coll Cardiol (1990) 1.73
Oestrogen receptors and the response to endocrine therapy in advanced breast cancer. Br J Cancer (1978) 1.71
High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. Proc Natl Acad Sci U S A (2000) 1.69
Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry (1988) 1.68
Novel observations with FDOPA-PET imaging after early nigrostriatal damage. Mov Disord (2001) 1.68
Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers. J Pediatr (1995) 1.67
Multiple cis elements regulate an alternative splicing event at 4.1R pre-mRNA during erythroid differentiation. Blood (2001) 1.66
Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol (1998) 1.64
Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group. Br J Cancer (1996) 1.64
Oestrogen receptor concentration in primary breast cancer and axillary node metastases. Breast Cancer Res Treat (1981) 1.64
Endothelium-dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X. Circulation (1999) 1.64
Functional anatomy of human procedural learning determined with regional cerebral blood flow and PET. J Neurosci (1992) 1.64
Intrascleral dissemination of infectious scleritis following pterygium excision. Br J Ophthalmol (1998) 1.63
Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood-brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumors with PET. J Cereb Blood Flow Metab (1986) 1.62
Assays for noninvasive imaging of reporter gene expression. Nucl Med Biol (1999) 1.62
Use of the abdominal aorta for arterial input function determination in hepatic and renal PET studies. J Nucl Med (1992) 1.59
Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol (1991) 1.57